ENTITY
Joinn Laboratories China  Lt

Joinn Laboratories China Lt (603127 CH)

58
Analysis
Health CareChina
Joinn Laboratories (China) Co., Ltd. operates as a medicines development company. The Company offers drug development, pharmaceutical analysis, pharmacologic testing, and other related services. Joinn Laboratories (China) also provides pesticide and medical device safety evaluation services.
more
16 Feb 2021 10:11

EM Remains Global Leadership -- Remain Overweight

Price and RS uptrends for the MSCI EM index continues to underpin our bullish outlook for emerging market equities -- remain overweight.

Logo
192 Views
Share
16 Feb 2021 09:44

Pre-IPO Joinn Laboratories - The Future Performance Is Worth Looking Forward To

This article analyzed JOINN Laboratories in terms of market potential, orders in hand and newly signed orders, equity structure and talent pool,...

Logo
985 Views
Share
15 Feb 2021 21:15

JOINN Laboratories IPO: Valuation First Look

JOINN is seeking to raise as much as $600 million through a HK IPO, according to press reports. In this note, we take a first look at the potential...

Logo
988 Views
Share
15 Feb 2021 10:32

ECM Weekly (14 February 2021) - Youran Dairy, Bairong, Joinn Lab, Bilibili HK,

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
10 Feb 2021 11:20

Joinn Laboratories IPO: Pioneer of Commercial GLP Laboratories in China Shows Promise

Joinn Laboratories, a non-clinical CRO focused on drug safety assessment has filed for a secondary listing on the Hong Kong Stock Exchange and...

Share
x